Dopamine D2/3- and μ-opioid receptor antagonists reduce cue-induced responding and reward impulsivity in humans

por Weber, S C, Beck-Schimmer, B, Kajdi, M-E, Müller, D, Tobler, P N, Quednow, B B
Publicado 2016

Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine (“Ecstasy”) induced cytoskeletal damage

por Bavato, F., Stamatakos, S., Ohki, C. M. Yde, Seifritz, E., Romualdi, P., Grünblatt, E., Quednow, B. B.
Publicado 2022

Nocturnal Gamma-Hydroxybutyrate Reduces Cortisol-Awakening Response and Morning Kynurenine Pathway Metabolites in Healthy Volunteers

por Dornbierer, D A, Boxler, M, Voegel, C D, Stucky, B, Steuer, A E, Binz, T M, Baumgartner, M R, Baur, D M, Quednow, B B, Kraemer, T, Seifritz, E, Landolt, H P, Bosch, O G
Publicado 2019

αCaMKII controls the establishment of cocaine's reinforcing effects in mice and humans

por Easton, A C, Lourdusamy, A, Havranek, M, Mizuno, K, Solati, J, Golub, Y, Clarke, T-K, Vallada, H, Laranjeira, R, Desrivières, S, Moll, G H, Mössner, R, Kornhuber, J, Schumann, G, Giese, K P, Fernandes, C, Quednow, B B, Müller, C P
Publicado 2014